Healthcare -
Biotechnology - NASDAQ - US
$ 12.08
1.94 %
$ 39.3 M
Market Cap
-0.71
P/E
SRZN - COST OF REVENUE
Cost of Revenue SRZN - Surrozen, Inc.
27.2 M
LAST VALUE
187.39%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR